Table 3 Clinical characteristics of LN patients

Pt

Age (years)

Disease duration (months)

C3 (g/L)

C4 (g/L)

ESR (mm/h)

CRP (mg/L)

WBC (*10^9/L)

RBC (*10^12/L)

Hb (g/L)

PLT (*10^9/L)

1

39

144

0.43

0.06

37

3.06

2.80

3.09

89.0

104

2

38

48

0.65

0.11

27

3.13

3.64

4.15

116.8

209

3

34

19

0.59

0.10

60

54.83

6.40

2.69

81.0

96

4

20

36

0.19

0.07

3

3.23

2.32

3.90

115.9

128

5

23

6

1.03

0.15

12

3.13

5.56

5.46

117.8

221

6

35

36

0.25

0.07

38

3.13

2.13

3.30

103.3

106

7

19

60

0.56

0.11

10

3.13

4.60

2.37

74.0

110

8

48

156

0.34

0.08

14

1.00

5.40

2.84

85.0

80

9

36

1

0.33

0.05

11

9.00

2.10

3.45

105.0

136

10

46

120

0.62

0.05

74

32.52

3.50

3.14

98.0

227

SLEDAI (score)

Pt

Creatinine (umol/L)

Urea (mmol/L)

eGFR (mL/min /1.73m²)

UTP (g/24 h)

RBC (/uL)

WBC (/uL)

Classification

AI (score)

CI (score)

1

59

5.03

111.223

8.30

95

56

IV-S(A) + V

9

0

9

2

63

4.50

107.899

2.52

26

4

III-(A)

8

1

8

3

130

12.44

46.224

6.03

252

94

IV-G(A) + V

19

3

11

4

51

3.85

133.345

2.07

50

0

III-(A/C)

6

1

12

5

58

7.11

109.314

2.03

50

0

III-(A) + V

0

0

6

6

135

12.40

38.299

6.25

92

22

IV-G(A/C)

10

2

4

7

77

4.90

96.472

2.82

350

12

IV-S(A)

9

0

8

8

56

10.36

98.682

6.39

45

22

IV-G(A)

15

0

5

9

69

4.31

98.028

2.35

184

50

IV-S(A)

9

0

4

10

59

6.91

93.006

1.40

37

28

IV-S(A)

7

0

4